Hypertrophic cardiomyopathy (HCM) is a complex genetic cardiovascular disease that often remains under-recognised, with ongoing challenges in diagnosis, risk stratification, and treatment. The HCM Knowledge Track brings together expert-selected resources — from congress presentations and trial updates to imaging insights, patient perspectives, and debates on therapeutic strategies. It offers a structured view of current evidence to support your understanding of diagnosis, guide your awareness of therapeutic advances, and broaden your perspective on expert debates relevant to practice.
ESC Content
Congress Session
Congress Presentation
Serial changes in left and right ventricular global longitudinal strain in symptomatic obstructive hypertrophic cardiomyopathy treated with mavacamten: insights from VALOR-HCM trial
2 September 2024
Congress Presentation
Mavacamten in a real-world hypertrophic cardiomyopathy population: how many may be eligible?
2 September 2024
Congress Presentation
Modern medical treatment is better than myomectomy for obstructive hypertrophic cardiomyopathy - discussion
30 August 2024
Congress Presentation
Modern medical treatment is better than myomectomy for obstructive hypertrophic cardiomyopathy: con
30 August 2024
Congress Presentation
Modern medical treatment is better than myomectomy for obstructive hypertrophic cardiomyopathy: pro
30 August 2024
Congress Presentation
Congress Presentation
Polygenic risk score for hypertrophic cardiomyopathy predicts population disease risk, penetrance in sarcomeric rare variant carriers and survival in cases
26 August 2023
Webinar
Diagnosis of hypertrophic cardiomyopathy from the stethoscope to tissue characterisation
10 January 2022
Webinar
The hypertrophied heart: how to get the best out of each imaging modality
20 December 2021
Congress Presentation
Mavacamten improves symptoms of shortness of breath in patients with obstructive hypertrophic cardiomyopathy (HCM): analysis of the HCM Symptom Questionnaire in the phase 3 EXPLORER trial
30 June 2021
Congress Session
Implications of obstructive hypertrophic cardiomyopathy (oHCM) for heart failure specialists
17 May 2025
Congress Session
Echo essentials for hypertrophic cardiomyopathy (HCM): the heartbeat of diagnosis and treatment
12 December 2024
Congress Session
Managing hypertrophic cardiomyopathy (HCM) in clinical practice: the patient journey
31 August 2024
Congress Session
Staging therapy in hypertrophic cardiomyopathy patients with heart failure: new insights
11 May 2024
Congress Session
Emerging perspectives in the diagnosis and management of hypertrophic cardiomyopathy
26 August 2023
